Quantitative Analysis Of Drugs In Pharmaceutical PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Quantitative Analysis Of Drugs In Pharmaceutical PDF full book. Access full book title Quantitative Analysis Of Drugs In Pharmaceutical by P. D. Sethi. Download full books in PDF and EPUB format.
Author: P. D. Sethi
Publisher:
ISBN: 9788123901794
Category : Drugs
Languages : en
Pages : 540
Get Book Here
Book Description
Author: P. D. Sethi
Publisher:
ISBN: 9788123901794
Category : Drugs
Languages : en
Pages : 540
Get Book Here
Book Description
Author: Prabhu Dayal Sethi
Publisher:
ISBN: 9788190000505
Category :
Languages : en
Pages : 478
Get Book Here
Book Description
Author: Donald Clarence. Garratt
Publisher: Springer Science & Business Media
ISBN: 1461333806
Category : Science
Languages : en
Pages : 937
Get Book Here
Book Description
General Monographs, Alphabetically Arranged and Consisting of Methods for Quantitative Determination of the Substance, its Salts, and Preparations of Which it is a Principal Con- Stituent.- Synthetic Organic Compounds, Methods for Determination of Substances not Included in the General Monographs.- Essential Oils.- Oils, Fats and Waxes.- Appendices.- I. Determination of Alcohol Content.- II. Complexometric Titrations.- III. Non-aqueous Titrations.- IV. The Oxygen-Flask Combustion Technique.- V. Determination of Water.- VI. Extraneous Matter in Food and Drugs.- VII. Microbiological Assays.- VII.
Author: D.C. Garratt
Publisher:
ISBN: 9788123907543
Category :
Languages : en
Pages :
Get Book Here
Book Description
Author: Donald Clarence. Garratt
Publisher: Springer
ISBN: 9780412148101
Category : Science
Languages : en
Pages : 926
Get Book Here
Book Description
Author: Donald Clarence Garratt
Publisher:
ISBN: 9781461333814
Category :
Languages : en
Pages : 944
Get Book Here
Book Description
Author: P. D. Sethi
Publisher:
ISBN: 9788123905600
Category : Drugs
Languages : en
Pages : 692
Get Book Here
Book Description
Author: Abdul W. Basit
Publisher: Springer
ISBN: 3319907557
Category : Medical
Languages : en
Pages : 240
Get Book Here
Book Description
3D printing is forecast to revolutionise the pharmaceutical sector, changing the face of medicine development, manufacture and use. Potential applications range from pre-clinical drug development and dosage form design through to the fabrication of functionalised implants and regenerative medicine. Within clinical pharmacy practice, printing technologies may finally lead to the concept of personalised medicines becoming a reality. This volume aims to be the definitive resource for anyone thinking of developing or using 3D printing technologies in the pharmaceutical sector, with a strong focus on the translation of printing technologies to a clinical setting. This text brings together leading experts to provide extensive information on an array of 3D printing techniques, reviewing the current printing technologies in the pharmaceutical manufacturing supply chain, in particular, highlighting the state-of-the-art applications in medicine and discussing modern drug product manufacture from a regulatory perspective. This book is a highly valuable resource for a range of demographics, including academic researchers and the pharmaceutical industry, providing a comprehensive inventory detailing the current and future applications of 3D printing in pharmaceuticals. Abdul W. Basit is Professor of Pharmaceutics at the UCL School of Pharmacy, University College London. Abdul’s research sits at the interface between pharmaceutical science and gastroenterology, forging links between basic science and clinical outcomes. He leads a large and multidisciplinary research group, and the goal of his work is to further the understanding of gastrointestinal physiology by fundamental research. So far, this knowledge has been translated into the design of new technologies and improved disease treatments, many of which are currently in late-stage clinical trials. He has published over 350 papers, book chapters and abstracts and delivered more than 250 invited research presentations. Abdul is also a serial entrepreneur and has filed 25 patents and founded 3 pharmaceutical companies (Kuecept, Intract Pharma, FabRx). Abdul is a frequent speaker at international conferences, serves as a consultant to many pharmaceutical companies and is on the advisory boards of scientific journals, healthcare organisations and charitable bodies. He is the European Editor of the International Journal of Pharmaceutics. Abdul was the recipient of the Young Investigator Award in Pharmaceutics and Pharmaceutical Technology from the American Association of Pharmaceutical Scientists (AAPS) and is the only non-North American scientist to receive this award. He was also the recipient of the Academy of Pharmaceutical Sciences (APS) award. Simon Gaisford holds a Chair in Pharmaceutics and is Head of the Department of Pharmaceutics at the UCL School of Pharmacy, University College London. He has published 110 papers, 8 book chapters and 4 authored books. His research is focused on novel technologies for manufacturing medicines, particularly using ink-jet printing and 3D printing, and he is an expert in the physico-chemical characterisation of compounds and formulations with thermal methods and calorimetry.
Author: Li Di
Publisher: Elsevier
ISBN: 0080557619
Category : Science
Languages : en
Pages : 549
Get Book Here
Book Description
Of the thousands of novel compounds that a drug discovery project team invents and that bind to the therapeutic target, typically only a fraction of these have sufficient ADME/Tox properties to become a drug product. Understanding ADME/Tox is critical for all drug researchers, owing to its increasing importance in advancing high quality candidates to clinical studies and the processes of drug discovery. If the properties are weak, the candidate will have a high risk of failure or be less desirable as a drug product. This book is a tool and resource for scientists engaged in, or preparing for, the selection and optimization process. The authors describe how properties affect in vivo pharmacological activity and impact in vitro assays. Individual drug-like properties are discussed from a practical point of view, such as solubility, permeability and metabolic stability, with regard to fundamental understanding, applications of property data in drug discovery and examples of structural modifications that have achieved improved property performance. The authors also review various methods for the screening (high throughput), diagnosis (medium throughput) and in-depth (low throughput) analysis of drug properties. Serves as an essential working handbook aimed at scientists and students in medicinal chemistry Provides practical, step-by-step guidance on property fundamentals, effects, structure-property relationships, and structure modification strategies Discusses improvements in pharmacokinetics from a practical chemist's standpoint
Author: Richard B. Silverman
Publisher: Elsevier
ISBN: 0080513379
Category : Science
Languages : en
Pages : 650
Get Book Here
Book Description
Standard medicinal chemistry courses and texts are organized by classes of drugs with an emphasis on descriptions of their biological and pharmacological effects. This book represents a new approach based on physical organic chemical principles and reaction mechanisms that allow the reader to extrapolate to many related classes of drug molecules. The Second Edition reflects the significant changes in the drug industry over the past decade, and includes chapter problems and other elements that make the book more useful for course instruction. New edition includes new chapter problems and exercises to help students learn, plus extensive references and illustrations Clearly presents an organic chemist's perspective of how drugs are designed and function, incorporating the extensive changes in the drug industry over the past ten years Well-respected author has published over 200 articles, earned 21 patents, and invented a drug that is under consideration for commercialization